Cargando…
Heterogeneity in Melanoma
SIMPLE SUMMARY: Tumour heterogeneity is a phenomenon where the cancer cells evolve diversely over the course of the disease. As a result of the evolution, the cancer cells can be found to be genetically, epigenetically and/or phenotypically different in order to survive in the human body. The tumour...
Autores principales: | Ng, Mei Fong, Simmons, Jacinta L., Boyle, Glen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221188/ https://www.ncbi.nlm.nih.gov/pubmed/35740696 http://dx.doi.org/10.3390/cancers14123030 |
Ejemplares similares
-
BRN2 expression increases anoikis resistance in melanoma
por: Pierce, Carly J., et al.
Publicado: (2020) -
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
por: Neuendorf, Hannah M., et al.
Publicado: (2023) -
MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
por: Simmons, Jacinta L., et al.
Publicado: (2017) -
Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017) -
Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma
por: Oliveira Pinho, Jacinta, et al.
Publicado: (2019)